| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
59,530,000 |
| Market
Cap: |
189.90(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.37 - $8.64 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Clene is a clinical-stage pharmaceutical company focusing on the discovery, development, and commercialization of clean-surfaced nanotechnology therapeutics. Co. is focused on addressing the unmet medical needs in two areas: first, those related to central nervous system disorders including Amyotrophic Lateral Sclerosis, Multiple Sclerosis, and Parkinson's Disease; and second, those related to COVID-19, an infectious viral respiratory disease with serious and sometimes fatal co-morbidities. In addition to the development of clean-surfaced nanocrystals, Co.'s electro-crystal-chemistry platform can produce ionic solutions of various transition elements including silver, zinc, and others.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
122,819 |
8,214,276 |
| Total Buy Value |
$0 |
$0 |
$583,390 |
$6,959,305 |
| Total People Bought |
0 |
0 |
3 |
5 |
| Total Buy Transactions |
0 |
0 |
3 |
7 |
| Total Shares Sold |
4,393 |
4,393 |
4,393 |
62,893 |
| Total Sell Value |
$16,478 |
$16,478 |
$16,478 |
$38,995 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
6 |
6 |
6 |
10 |
| End Date |
2025-03-04 |
2024-12-01 |
2024-06-02 |
2023-06-03 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  General Resonance Llc |
10% Owner |
– – • |
2025-05-30 |
4 |
S |
$2.80 |
$1,148 |
D/D |
(410) |
709,192 |
|
- |
|
| General Resonance Llc |
10% Owner |
– – • |
2025-05-29 |
4 |
S |
$2.73 |
$1,119 |
D/D |
(410) |
709,602 |
|
- |
|
| General Resonance Llc |
10% Owner |
– – • |
2025-05-28 |
4 |
S |
$2.60 |
$1,090 |
D/D |
(420) |
710,012 |
|
-4% |
|
| General Resonance Llc |
10% Owner |
– – • |
2025-05-27 |
4 |
S |
$2.45 |
$1,029 |
D/D |
(420) |
710,432 |
|
-5% |
|
| General Resonance Llc |
10% Owner |
– – • |
2025-03-19 |
4 |
S |
$4.40 |
$6,160 |
D/D |
(1,400) |
710,852 |
|
36% |
|
| General Resonance Llc |
10% Owner |
– – • |
2025-03-18 |
4 |
S |
$4.45 |
$5,932 |
D/D |
(1,333) |
712,252 |
|
39% |
|
| Matlin David J |
|
– • – |
2024-09-30 |
4 |
B |
$4.75 |
$438,458 |
D/D |
92,307 |
444,491 |
0.01 |
-1% |
|
| Mosca Alison |
Director |
– • – |
2024-09-30 |
4 |
A |
$4.59 |
$730,107 |
I/I |
159,134 |
321,052 |
|
- |
|
| Etherington Robert Dee |
Chief Executive Officer |
• • – |
2024-09-30 |
4 |
B |
$4.75 |
$47,500 |
D/D |
10,000 |
40,149 |
0.01 |
-1% |
|
| Mortenson Mark |
Chief Science Officer |
• – – |
2024-09-30 |
4 |
B |
$4.75 |
$97,432 |
D/D |
20,512 |
28,949 |
0.01 |
-1% |
|
| Etherington Robert Dee |
Chief Executive Officer |
• • – |
2024-07-29 |
4 |
OE |
$3.00 |
$81,960 |
D/D |
27,320 |
30,149 |
|
- |
|
| General Resonance Llc |
10% Owner |
– – • |
2024-05-01 |
4 |
S |
$0.40 |
$5,148 |
D/D |
(13,000) |
15,313,712 |
|
30% |
|
| General Resonance Llc |
10% Owner |
– – • |
2024-04-30 |
4 |
S |
$0.42 |
$5,416 |
D/D |
(13,000) |
15,326,712 |
|
33% |
|
| General Resonance Llc |
10% Owner |
– – • |
2024-04-24 |
4 |
S |
$0.33 |
$3,278 |
D/D |
(10,000) |
15,349,712 |
|
1% |
|
| General Resonance Llc |
10% Owner |
– – • |
2024-04-09 |
4 |
S |
$0.38 |
$8,675 |
D/D |
(22,500) |
15,428,212 |
|
34% |
|
| Matlin David J |
|
– • – |
2023-11-10 |
4 |
B |
$0.41 |
$102,501 |
D/D |
250,002 |
7,043,686 |
0.01 |
-1% |
|
| Kiernan Matthew |
|
– • – |
2023-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,540 |
|
-2% |
|
| Desai Arjun Jj |
|
– • – |
2023-09-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
16,298 |
|
-2% |
|
| Etherington Robert Dee |
Chief Executive Officer |
• • – |
2023-06-26 |
4 |
B |
$0.81 |
$20,250 |
I/I |
25,000 |
25,000 |
0.01 |
-53% |
|
| Stevens John Henry |
|
– • – |
2023-06-26 |
4 |
B |
$0.80 |
$253,164 |
D/D |
316,455 |
800,204 |
0.01 |
-53% |
|
| Ugwumba Chidozie |
Resigned as director 2/15/2023 |
– – • |
2023-06-16 |
4 |
B |
$0.80 |
$6,000,000 |
I/I |
7,500,000 |
13,018,908 |
1.5 |
-49% |
|
| Wilcox Reed N |
|
– • – |
2022-11-14 |
4 |
OE |
$0.15 |
$26,237 |
D/D |
174,912 |
575,145 |
|
- |
|
| Matlin David J |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$2,900,000 |
D/D |
2,871,287 |
5,293,684 |
0.01 |
25% |
|
| Ugwumba Chidozie |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$1,000,000 |
I/I |
990,099 |
5,518,908 |
0.01 |
25% |
|
| Gay Jonathon |
|
– • – |
2022-11-02 |
4 |
B |
$1.01 |
$1,000,000 |
I/I |
990,099 |
2,154,848 |
0.01 |
25% |
|
83 Records found
|
|
Page 1 of 4 |
|
|
0.45 (16.42%) 
